Premier Biomedical, Inc. (BIEI)

OTCMKTS: BIEI · Delayed Price · USD
0.0012
0.00 (0.00%)
Apr 22, 2024, 1:45 PM EDT - Market closed
Market Cap 1.20M
Revenue (ttm) n/a
Net Income (ttm) -202,173
Shares Out 999.98M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 806,228
Open 0.0013
Previous Close 0.0012
Day's Range 0.0012 - 0.0013
52-Week Range 0.0005 - 0.0017
Beta -4.17
Analysts n/a
Price Target n/a
Earnings Date n/a

About BIEI

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more]

Sector Healthcare
Founded 2010
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol BIEI
Full Company Profile

Financial Performance

Financial Statements

News

Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology

Premier, N/K/A Nova-Graphene Ballistics, Inc., has Acquired the Rights to Use, Within the United States, this Proprietary Technology for Lightweight, Extremely Protective, Graphene Ballistic Plate Pro...

1 year ago - GlobeNewsWire